The European Commission's public consultation on proposed revisions to the In Vitro Diagnostics Directive (98/79/EC) contains a section on "conditional CE marking" that has caught the attention of European medtech industry association Eucomed1. John Brennan, Eucomed's director of technical & regulatory affairs, told RAJ Devices that, although IVDs did not fall within Eucomed's scope per se, the trade association would be analysing this particular issue because "it could be an interesting vehicle for innovation in Europe"...
Scrip Regulatory Affairs
"Conditional CE marking" - a new concept in device innovation?
01 July 2010
Karen Finn
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU publishes draft regulation on e-labelling of medical devices
- Spain passes generic policy-tightening decree affecting medtech and pharma
- EMA responds to criticism of reflection paper on non-clinical studies for generic nano-particle iron medicinal product applications
- EMA responds to criticism of reflection paper on non-clinical studies for generic nano-particle iron medicinal product applications
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
